首頁 > 市場調查報告書 > 醫療設備

體外診斷感染疾病

市場調查報告書

商品編碼

1863873

梅毒檢測市場：按梅毒類型、檢測方法、檢體地點、樣本類型、產品形式、技術、最終用戶和地區分類

Syphilis Testing Market, By Type of Syphilis, By Test Methodology, By Location of Testing, By Specimen Type, By Product Format, By Technology, By End User, By Geography

出版日期: 2025年10月28日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2025 年，梅毒檢測市場價值將達到 11.9 億美元，到 2032 年將達到 26.1 億美元，2025 年至 2032 年的複合年成長率為 11.9%。

報告範圍		報告詳情
基準年：	2024	2025年市場規模：	11.9億美元
性能數據：	2020年至2024年	預測期：	2025年至2032年
預測期（2025-2032年）複合年成長率：	11.90%	2032 年價值預測：	26.1億美元

全球梅毒檢測市場是整個感染疾病診斷產業的重要組成部分，主要關注梅毒的檢測和診斷，梅毒是一種由梅毒螺旋體引起的性行為感染傳染病。

梅毒檢測包括多種調查方法，例如傳統的血清學檢測、快速診斷檢測以及先進的分子診斷技術，例如基於PCR的檢測。儘管梅毒是一種可以透過適當的抗生素治療治癒的感染疾病，但由於全球範圍內，特別是已開發國家梅毒病例的再次出現，該市場正受到廣泛關注。

世界各地的醫療衛生系統正在實施全面的篩檢計劃，尤其關注高風險族群、孕婦和有多個性伴侶的人群，這推動了對準確快速診斷解決方案的需求。檢測方法包括梅毒螺旋體檢測和非梅毒螺旋體檢測，每種檢測方法在感染的不同階段都發揮特定的診斷作用。

就地檢驗設備透過提供即時結果，徹底改變了梅毒的診斷方式，使其在資源匱乏地區和急診室尤為重要。數位健康技術和實驗室自動化的整合進一步提高了檢測效率和結果準確性。公共衛生舉措、監管指南以及公眾對性行為感染日益成長的認知，持續影響著市場動態，凸顯了早期發現和治療對於預防疾病進展和傳播的重要性。

市場動態

全球梅毒檢測市場的成長主要受全球梅毒發病率驚人上升的推動。世界衛生組織（世衛組織）報告稱，已開發國家的病例顯著增加，這迫切需要全面的檢測解決方案。人們對性行為感染傳染病及其長期健康後果（包括先天性梅毒的傳播）的認知不斷提高，促使篩檢計畫擴大規模，並在醫療機構實施常規檢測通訊協定。

政府政策，例如推廣性健康教育和強制孕婦進行性健康檢測，是推動成長要素。同時，快速診斷測試和分子診斷技術的進步提高了檢測準確性，縮短了出結果的時間。在偏遠和醫療資源匱乏地區，就地檢驗設備的日益普及有助於解決可近性問題，並促進市場擴張。

然而，市場仍存在諸多限制因素，包括與性行為感染傳染病相關的社會污名，這往往導致檢測率低和診斷延遲。先進診斷設備的高成本以及發展中地區醫療基礎設施的匱乏，都構成了市場滲透的重大障礙。此外，診斷設備核准的複雜法規以及各國不同的檢測指南也為市場相關人員帶來了額外的挑戰。

儘管有這些限制，但創新檢測技術的發展仍蘊藏著巨大的機遇，例如基於智慧型手機的診斷解決方案和用於結果解讀的整合人工智慧平台。遠端醫療領域的蓬勃發展為遠距檢測諮詢和後續服務開闢了新的途徑。診斷公司與醫療服務提供者之間的策略合作，以及政府和非政府組織對性健康項目的投入不斷增加，正在為市場成長創造有利條件，尤其是在梅毒高發且檢測基礎設施亟待發展的新興經濟體。

本次調查的主要特點

本報告對全球梅毒檢測市場進行了詳細分析，以 2024 年為基準年，給出了預測期（2025-2032 年）內的市場規模（十億美元）和復合年成長率（%）。
該報告還重點介紹了各個細分市場的潛在商機，並概述了該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、阻礙因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
該報告根據以下參數對全球梅毒檢測市場的主要企業進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
本報告的目標受眾是全球梅毒檢測市場的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過用於分析全球梅毒檢測市場的各種策略矩陣輕鬆做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1.19 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.90%	2032 Value Projection:	USD 2.61 Bn

Syphilis testing encompasses various diagnostic methodologies including traditional serological tests, rapid diagnostic tests, and advanced molecular diagnostic techniques such as PCR-based assays. The market has gained significant attention due to the resurgence of syphilis cases worldwide, particularly in developed countries, despite being a curable infection with appropriate antibiotic treatment.

Healthcare systems globally are implementing comprehensive screening programs, especially for high-risk populations, pregnant women, and individuals with multiple sexual partners, driving the demand for accurate and rapid diagnostic solutions. The testing landscape includes both treponemal and non-treponemal tests, each serving specific diagnostic purposes in different stages of infection.

Point-of-care testing devices have revolutionized syphilis diagnosis by providing immediate results, particularly beneficial in resource-limited settings and emergency departments. The integration of digital health technologies and laboratory automation has further enhanced testing efficiency and result accuracy. Public health initiatives, regulatory guidelines, and increasing awareness about sexually transmitted infections continue to shape the market dynamics, emphasizing the importance of early detection and treatment to prevent disease progression and transmission.

Market Dynamics

The global syphilis testing market is primarily driven by the alarming rise in syphilis incidence rates worldwide, with the World Health Organization reporting significant increases in developed nations, creating urgent demand for comprehensive testing solutions. Growing awareness about sexually transmitted infections and their long-term health consequences, including congenital syphilis transmission, has led to expanded screening programs and routine testing protocols in healthcare facilities.

Government initiatives promoting sexual health education and mandatory testing for pregnant women serve as key growth catalysts, while technological advancements in rapid diagnostic tests and molecular diagnostics have improved testing accuracy and reduced turnaround times. The increasing adoption of point-of-care testing devices in remote and underserved areas addresses accessibility challenges and supports market expansion.

However, the market faces significant restraints including social stigma associated with sexually transmitted infections, which often leads to reduced testing compliance and delayed diagnosis. High costs of advanced diagnostic equipment and limited healthcare infrastructure in developing regions pose substantial barriers to market penetration. Regulatory complexities surrounding diagnostic device approvals and varying testing guidelines across different countries create additional challenges for market players.

Despite these constraints, substantial opportunities exist in the development of innovative testing technologies, including smartphone-based diagnostic solutions and artificial intelligence-integrated platforms for result interpretation. The expanding telemedicine sector presents new avenues for remote testing consultation and follow-up services. Strategic partnerships between diagnostic companies and healthcare providers, along with increasing investments in sexual health programs by government and non-government organizations, create favorable conditions for market growth, particularly in emerging economies where syphilis prevalence remains high and testing infrastructure requires significant development.

Key Features of the Study

This report provides in-depth analysis of the global syphilis testing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global syphilis testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, BD (Becton, Dickinson and Company), Siemens Healthineers, bioMerieux, Hologic, Cepheid, Bio-Rad Laboratories, Thermo Fisher Scientific, Ortho Clinical Diagnostics, QuidelOrtho, Trinity Biotech, SD Biosensor, Healgen Scientific, and Mologic
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global syphilis testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global syphilis testing market

Market Segmentation

Type of Syphilis Insights (Revenue, USD Bn, 2020 - 2032)
- Primary and Secondary Syphilis
- Latent and Tertiary Syphilis
Test Methodology Insights (Revenue, USD Bn, 2020 - 2032)
- Serological Tests
- Non-Treponemal Tests (e.g., RPR, VDRL)
- Treponemal Tests (e.g., TPHA, FTA-ABS)
- Molecular Diagnostics
- Nucleic Acid Amplification Tests (NAATs)
- Polymerase Chain Reaction (PCR)
Location of Testing Insights (Revenue, USD Bn, 2020 - 2032)
- Laboratory Testing
- Point-of-Care (POC) Testing
Specimen Type Insights (Revenue, USD Bn, 2020 - 2032)
- Serum/Plasma
- Whole Blood
- Oral Fluid
- Dried Blood Spot (DBS)
Product Format Insights (Revenue, USD Bn, 2020 - 2032)
- Diagnostic Kits
- Reagents and Consumables
- Instruments and Analyzers
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescent Immunoassay (CLIA)
- Lateral Flow Assays (LFA)
- Rapid Plasma Reagin (RPR)
- Treponemal Particle Agglutination (TPPA)
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Diagnostic Laboratories
- Point-of-Care (POC) Settings
- Home Care/Self-Testing
- Others (Academic and Research Institutes)
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Roche Diagnostics
- Abbott Laboratories
- BD (Becton, Dickinson and Company)
- Siemens Healthineers
- bioMerieux
- Hologic
- Cepheid
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Ortho Clinical Diagnostics
- QuidelOrtho
- Trinity Biotech
- SD Biosensor
- Healgen Scientific
- Mologic

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Syphilis Testing Market, By Type of Syphilis
- Global Syphilis Testing Market, By Test Methodology
- Global Syphilis Testing Market, By Location of Testing
- Global Syphilis Testing Market, By Specimen Type
- Global Syphilis Testing Market, By Product Format
- Global Syphilis Testing Market, By Technology
- Global Syphilis Testing Market, By End User
- Global Syphilis Testing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Syphilis Testing Market, By Type of Syphilis, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Primary and Secondary Syphilis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Latent and Tertiary Syphilis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Syphilis Testing Market, By Test Methodology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Serological Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Non-Treponemal Tests (e.g., RPR, VDRL)
Treponemal Tests (e.g., TPHA, FTA-ABS)
Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Nucleic Acid Amplification Tests (NAATs)
Polymerase Chain Reaction (PCR)

6. Global Syphilis Testing Market, By Location of Testing, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Laboratory Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Point-of-Care (POC) Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Syphilis Testing Market, By Specimen Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Serum/Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Whole Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral Fluid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dried Blood Spot (DBS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Syphilis Testing Market, By Product Format, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Diagnostic Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Reagents and Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Instruments and Analyzers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Syphilis Testing Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Enzyme-Linked Immunosorbent Assay (ELISA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chemiluminescent Immunoassay (CLIA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Lateral Flow Assays (LFA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rapid Plasma Reagin (RPR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Treponemal Particle Agglutination (TPPA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Syphilis Testing Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Point-of-Care (POC) Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care/Self-Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Academic and Research Institutes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Syphilis Testing Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type of Syphilis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Test Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Location of Testing, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type of Syphilis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Test Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Location of Testing, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type of Syphilis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Test Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Location of Testing, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type of Syphilis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Test Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Location of Testing, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type of Syphilis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Test Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Location of Testing, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type of Syphilis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Test Methodology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Location of Testing, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Format, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

12. Competitive Landscape

Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BD (Becton, Dickinson and Company)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
bioMerieux
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hologic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cepheid
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ortho Clinical Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QuidelOrtho
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Trinity Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SD Biosensor
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Healgen Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mologic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies